This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novartis Ag. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: The Innovations of Andrew Weiss
Introduction
Andrew Weiss is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medicine through his innovative work on cyclic peptides. With a total of 2 patents, Weiss has focused on developing compounds that have the potential to treat various diseases.
Latest Patents
Weiss's latest patents revolve around cyclic peptides and their use as medicines. The inventions provide compounds that are non-immunosuppressive, cyclophilin-binding, mPTP blockers. These compounds are useful for the prevention or treatment of diseases such as HCV infection, stroke, multiple sclerosis, HBV infection, HPV infection, asthma, cancer, muscular dystrophy, sepsis, ischemia/reperfusion injury, and heart failure.
Career Highlights
Andrew Weiss is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development in the pharmaceutical field, contributing to advancements in medical treatments.
Collaborations
Weiss has collaborated with notable colleagues, including Jiping Fu and Subramanian Karur. These collaborations have enhanced his research efforts and have led to significant advancements in his field.
Conclusion
Andrew Weiss is a prominent inventor whose work on cyclic peptides has the potential to revolutionize treatments for various diseases. His contributions to Novartis AG and collaborations with esteemed colleagues highlight his commitment to innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile